Ascletis' Series B Round

Ascletis raised a round of funding on January 03, 2017.

Ascletis is a biotechnology company dedicated to discovering, developing and commercializing new treatments for infectious diseases and cancer. Ascletis is focused on clinical development and commerci…

Articles about Ascletis' Series B Round: